Stock 9969 INNOCARE PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus InnoCare Pharma Limited

Equities

9969

KYG4783B1032

Market Closed - Hong Kong S.E.
Other stock markets
 01:38:20 26/04/2024 pm IST 		5-day change 1st Jan Change
4.45 HKD +1.37% Intraday chart for InnoCare Pharma Limited +9.61% -35.41%
29/03 InnoCare Pharma Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib CI
28/03 Transcript : InnoCare Pharma Limited, 2023 Earnings Call, Mar 28, 2024

Evolution of the average Target Price on InnoCare Pharma Limited

Price target over the last 5 years

History of analyst recommendation changes

25c7ac81812342.zUksRKdnxXq02VoLd8puymfMbCcYZIRK70rY9LfZ0qo.oAZvdvUlkC71n3dqHLkUmh2NIGBwI7J9uh--s8C7n9uHDWEylSr9Jf2qag~26d88c64cf5d68ff938eb81b1badd9ad

Analyst Recommendations on InnoCare Pharma Limited

UBS Adjusts InnoCare Pharma’s Price Target to HK$16.20 From HK$17.70, Keeps at Buy MT
UBS Upgrades InnoCare Pharma to Buy From Neutral, Adjusts Price Target to HK$17.70 From HK$23.20 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
4.119 CNY
Average target price
8.987 CNY
Spread / Average Target
+118.18%
High Price Target
13.72 CNY
Spread / Highest target
+233.19%
Low Price Target
5.794 CNY
Spread / Lowest Target
+40.66%

Consensus detail

Consensus revision (last 18 months)

Analysts covering InnoCare Pharma Limited

UBS

Ratings for InnoCare Pharma Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 9969 Stock
  4. Consensus InnoCare Pharma Limited